News/Companies/ASTH

ASTH News

Astrana Health, Inc. to Participate in Upcoming Investor Conference

ALHAMBRA, Calif., Jan. 6, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality,...

January 6, 2026

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

(NASDAQ:ASTH) ALHAMBRA, Calif., Sept. 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible,...

September 2, 2025Investor Events

Astrana Health Sees Q2 Sales $615.000M-$655.000M vs $660.68M Est

May 8, 2025

Astrana Health Affirms FY2025 Sales Guidance of $2.50B-$2.70B vs $2.73B Est

May 8, 2025

Astrana Health Q1 EPS $0.14 Misses $0.23 Estimate, Sales $620.39M Miss $630.68M Estimate

May 8, 2025

Assessing Astrana Health: Insights From 6 Financial Analysts

April 1, 2025

Barclays Initiates Coverage On Astrana Health with Equal-Weight Rating, Announces Price Target of $36

April 1, 2025

Truist Securities Maintains Buy on Astrana Health, Lowers Price Target to $46

March 18, 2025

What 4 Analyst Ratings Have To Say About Astrana Health

March 4, 2025

B of A Securities Maintains Buy on Astrana Health, Lowers Price Target to $49

March 4, 2025

Baird Maintains Outperform on Astrana Health, Lowers Price Target to $50

March 3, 2025

Astrana Health Q4 2024 GAAP EPS $(0.15) Misses $0.11 Estimate, Sales $665.20M Beat $617.24M Estimate

February 27, 2025

Stifel Maintains Buy on Astrana Health, Lowers Price Target to $56

February 20, 2025

Truist Securities Maintains Buy on Astrana Health, Lowers Price Target to $50

January 13, 2025